Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary IgA-nephropathy”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Not applicableLooking for participantsNCT04858724
What this trial is testing

The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)

Who this might be right for
IgA Nephropathy
Ruijin Hospital 2,000
Testing effectiveness (Phase 2)Study completedNCT03453619
What this trial is testing

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

Who this might be right for
IgA NephropathyLupus NephritisMembranous Nephropathy+2 more
Apellis Pharmaceuticals, Inc. 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06635772
What this trial is testing

The Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA Nephropathy

Who this might be right for
Immunoglobulin a Nephropathy
Hansoh BioMedical R&D Company 90
Post-approval studies (Phase 4)Not Yet RecruitingNCT06528015
What this trial is testing

Efficacy and Safety of Probiotics Combined With Enteric-coated Budesonide Capsules in Patients With Primary IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGAProbioticsBudesonide
Gang Xu 206
Testing effectiveness (Phase 2)Looking for participantsNCT06466135
What this trial is testing

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Who this might be right for
Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences 96
Testing effectiveness (Phase 2)Looking for participantsNCT07182227
What this trial is testing

PS-002 for the Treatment of IgA Nephropathy in Adults

Who this might be right for
Immunoglobulin A (IgA) Nephropathy
Purespring Therapeutics Limited 32
Testing effectiveness (Phase 2)Study completedNCT01738035
What this trial is testing

The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 150
Post-approval studies (Phase 4)UnknownNCT05824390
What this trial is testing

A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy

Who this might be right for
IgA Nephropathy
XIEJINGYUAN 116
Testing effectiveness (Phase 2)Ended earlyNCT05847920
What this trial is testing

Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd 53
Large-scale testing (Phase 3)Looking for participantsNCT07390123
What this trial is testing

Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

Who this might be right for
IgA Nephropathy (IgAN)
Haisco Pharmaceutical Group Co., Ltd. 370
Testing effectiveness (Phase 2)Ended earlyNCT04905212
What this trial is testing

Telitacicept for Injection (RC18) in Subjects With IgA Nephropathy

Who this might be right for
IgA Nephropathy
RemeGen Co., Ltd. 15
Large-scale testing (Phase 3)Study completedNCT04578834
What this trial is testing

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

Who this might be right for
IgA Nephropathy
Novartis Pharmaceuticals 518
Not applicableLooking for participantsNCT07074951
What this trial is testing

Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy

Who this might be right for
Primary IgA-nephropathyHigh-riskCaucasians
St. Petersburg State Pavlov Medical University 240
Testing effectiveness (Phase 2)Ended earlyNCT05162066
What this trial is testing

Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)

Who this might be right for
Complement 3 GlomerulopathyImmunoglobulin A NephropathyMembranous Nephropathy
BioCryst Pharmaceuticals 2
Post-approval studies (Phase 4)UnknownNCT02765594
What this trial is testing

Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Peking Union Medical College Hospital 98
Testing effectiveness (Phase 2)Looking for participantsNCT06670352
What this trial is testing

Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients with Primary IgAN

Who this might be right for
IgA Nephropathy (IgAN)
Haisco Pharmaceutical Group Co., Ltd. 80
Post-approval studies (Phase 4)Looking for participantsNCT06712407
What this trial is testing

Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

Who this might be right for
IgA Nephropathy
Calliditas Therapeutics AB 60
Not applicableUnknownNCT00378443
What this trial is testing

ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT

Who this might be right for
Glomerulonephritis, IGA
Peking University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06687174
What this trial is testing

Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy (IgAN)
Wuhan Createrna Science and Technology Co., Ltd 72
Post-approval studies (Phase 4)Ended earlyNCT02523768
What this trial is testing

Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment

Who this might be right for
GlomerulonephritisIgAN
Centre Hospitalier Universitaire de Saint Etienne 117
Load More Results